Point72 Hong Kong’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-157
Closed -$9K 1897
2022
Q1
$9K Buy
157
+151
+2,517% +$8.66K ﹤0.01% 1133
2021
Q4
$1K Buy
+6
New +$1K ﹤0.01% 1268
2021
Q1
Sell
-1
Closed 1659
2020
Q4
$0 Sell
1
-51
-98% ﹤0.01% 1607
2020
Q3
$9K Buy
+52
New +$9K ﹤0.01% 1006
2018
Q4
Sell
-61
Closed -$15K 1186
2018
Q3
$15K Buy
61
+40
+190% +$9.84K 0.01% 618
2018
Q2
$6K Buy
+21
New +$6K ﹤0.01% 695